Crizotinib - Document - PDFSEARCH.IO - Document Search Engine

First Page		Document Content
Date: 2010-11-01 17:47:52 Biology ALK inhibitor Organofluorides Crizotinib Anaplastic lymphoma kinase Anaplastic large-cell lymphoma Non-small-cell lung carcinoma ALK Inflammatory myofibroblastic tumour Medicine Lung cancer Chemistry		Add to Reading List Source URL: www.amp.org Download Document from Source Website File Size: 108,83 KB Share Document on Facebook

	PDF Document DocID: 1npVD - View Document
	Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016 DocID: 1mHtD - View Document
	Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev DocID: 1lzQ3 - View Document
	Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a DocID: 1gnav - View Document
	Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a DocID: 1abrR - View Document